-Cenexi, the French CDMO acquired in FY24, posted 8% YoY revenue growth in Q4 but remained EBITDA-negative
Despite FDA registration , they are not FDA approved , offer no medical care, lack clinical evidence for effectiveness, misuse GLP-1 terminology in marketing, and have mixed reviews with many users reporting no results
Activation of dopamine D4 receptors is protective against hypoxia/reoxygenation-induced cell death in HT22 cells
Going into GLP-1 therapy with the assumption that weight loss is the only path to happiness is likely to be a setup for disappointment, she says
Tirzepatide units conversion for compounded vials Compounded tirzepatide commonly comes in concentrations of 10 mg/mL or 20 mg/mL
Robert Kushner: I think both are correct